Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490412 · ClinicalTrials.gov registry record · NA
Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
A NA study of HIV Infections, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
- 15
- Study locations
NCT00490412 is a NA study of HIV Infections that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 207 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (53% lower). The trial reports 15 study locations across 10 states.
The verdict
NCT00490412, a NA study of HIV Infections, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to test the effects of Vitamin D on renal phosphate and bone loss, which are common in HIV infected adolescents and young adults being treated with tenofovir.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D supplement
Study Locations (15)
Florida
- Children's Diagnostic and Treatment Center - Fort Lauderdale
- University of Miami - Miami
- University of South Florida - Tampa
California
- Children's Hopsital of Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
Illinois
- Stroger Hospital of Cook County - Chicago
- Childrens Memorial Hospital - Chicago
New York
- Mount Sinai Hospital - New York
- Montefiore Medical Center - The Bronx
District of Columbia
- Children's National Medical Center - Washington D.C.
Louisiana
- Tulane University - New Orleans
Maryland
- University of Maryland Medical School - Baltimore
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490412
The ClinicalTrials.gov registry entry for NCT00490412 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (53% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00490412 reports 15 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT00490412 about?
NCT00490412 is a clinical study titled "Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection". The purpose of this study is to test the effects of Vitamin D on renal phosphate and bone loss, which are common in HIV infected adolescents and young adults being treated with tenofovir.
What is the current status of trial NCT00490412?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2007-12. Estimated completion is 2010-01.
What conditions does trial NCT00490412 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00490412?
The interventions under investigation include: Placebo (OTHER), Vitamin D supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00490412?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00490412 being conducted?
This trial has 15 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.